Old Web
English
Sign In
Acemap
>
authorDetail
>
Michael Davenport
Michael Davenport
Pharmaceutical Product Development
Alogliptin
Pharmacology
Medicine
Dipeptidyl peptidase-4 inhibitor
Tolerability
3
Papers
255
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Pharmacokinetics of alogliptin when administered with food, metformin, or cimetidine: a two-phase, crossover study in healthy subjects.
2010
CP | Principles and Practice of Constraint Programming
Aziz Karim
Paul Covington
Ronald J. Christopher
Michael Davenport
P. Fleck
Li X
Elisabeth R. Wann
Qais Mekki
Show All
Source
Cite
Save
Citations (33)
Pharmacokinetics, pharmacodynamics, and tolerability of single increasing doses of the dipeptidyl peptidase-4 inhibitor alogliptin in healthy male subjects.
2008
Clinical Therapeutics
Ronald J. Christopher
Paul Covington
Michael Davenport
P. Fleck
Qais Mekki
Elisabeth R. Wann
Aziz Karim
Show All
Source
Cite
Save
Citations (111)
1